Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.
Donahue
Timothy R
TR
Department of Surgery, Division of General Surgery, David Geffen School of Medicine at University of California Los Angeles, 10833 Le Conte Avenue, CHS, Room 72-215, Los Angeles, CA 90095-6904, USA. tdonahue@mednet.ucla.edu
Kazanjian
Kevork K
KK
Isacoff
William H
WH
Reber
Howard A
HA
Hines
O Joe
OJ
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006971:Hypersplenism / Q000209:etiology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies; D013156:Splenectomy; D013162:Splenic Vein; D016019:Survival Analysis; D013921:Thrombocytopenia / Q000209:etiology; D020246:Venous Thrombosis / Q000209:etiology / Q000601:surgery*
D000970:Antineoplastic Agents